Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: Paclitaxel
Drug: bevacizumab

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 722

Registration Number: NCT00028990

Locations: 🇺🇸
CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
CentraCare Health Plaza, Saint Cloud, Minnesota, United States

and more 27 locations

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00014118

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
Mercy Hospital and Medical Center, Chicago, Illinois, United States
🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 44 locations

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Phase 2

Terminated

Conditions: Leukemia

Interventions: Drug: Cyclophosphamide
Drug: Methotrexate
Drug: Prednisone

First Posted Date: 2003-01-27

Last Posted Date: 2023-07-05

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 59

Registration Number: NCT00003910

Locations: 🇺🇸
Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States
🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
🇺🇸
McFarland Clinic, PC, Ames, Iowa, United States

and more 65 locations

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Biological: PEG-interferon alfa-2b

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-29

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 32

Registration Number: NCT00049530

Locations: 🇺🇸
Aultman Cancer Center at Aultman Hospital, Canton, Ohio, United States
🇺🇸
MetroHealth Cancer Care Center at MetroHealth Medical Center, Cleveland, Ohio, United States
🇺🇸
UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States

and more 29 locations

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00006390

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸
CCOP - Marshfield Clinic Research Foundation, Marshfield, Wisconsin, United States

and more 11 locations

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Phase 2

Completed

Conditions: Sarcoma
Kidney Cancer
Ovarian Cancer
Metastatic Cancer
Melanoma (Skin)

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00003308

Locations: 🇺🇸
Iowa Methodist Medical Center, Des Moines, Iowa, United States
🇺🇸
Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸
Veterans Affairs Medical Center - Madison, Madison, Wisconsin, United States

and more 11 locations

Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 33

Registration Number: NCT00003309

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville, Tennessee, United States
🇺🇸
Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

and more 11 locations

Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia

Phase 3

Completed

Conditions: Leukemia

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-18

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 280

Registration Number: NCT00003764

Locations: 🇺🇸
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
CCOP - Virginia Mason Research Center, Seattle, Washington, United States

and more 215 locations

Flecainide in Treating Patients With Chronic Neuropathic Pain

Phase 2

Completed

Conditions: Pain

First Posted Date: 2003-01-27

Last Posted Date: 2023-06-15

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 20

Registration Number: NCT00002996

Locations: 🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States

and more 3 locations

Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma

Phase 3

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2009-02-09

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 427

Registration Number: NCT00052923

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy